Hepatitis C Antibody Testing in a Commercially Insured Population, 2005–2014
- 1 May 2017
- journal article
- Published by Elsevier in American Journal of Preventive Medicine
- Vol. 52 (5) , 625-631
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Rising Mortality Associated With Hepatitis C Virus in the United States, 2003–2013Clinical Infectious Diseases, 2016
- Awareness of Hepatitis C Virus Seropositivity and Chronic Infection in the Hispanic Community Health Study/Study of Latinos (HCHS/SOL)Journal of Immigrant and Minority Health, 2016
- Early View of the Effectiveness of New Direct-Acting Antiviral (DAA) Regimens in Patients with Hepatitis C Virus (HCV)Advances in Therapy, 2015
- Toward a more accurate estimate of the prevalence of hepatitis C in the United StatesHepatology, 2015
- Achieving sustained virologic response in hepatitis C: a systematic review of the clinical, economic and quality of life benefitsBMC Infectious Diseases, 2015
- Epidemiology of hepatocellular carcinoma in the United States: Where are we? Where do we go?Hepatology, 2014
- Screening for Hepatitis C Virus Infection in Adults: A Systematic Review for the U.S. Preventive Services Task ForceAnnals of Internal Medicine, 2013
- Awareness of infection, knowledge of hepatitis C, and medical follow-up among individuals testing positive for hepatitis C: National Health and Nutrition Examination Survey 2001–2008Hepatology, 2011
- Increasing Prevalence of HCC and Cirrhosis in Patients With Chronic Hepatitis C Virus InfectionGastroenterology, 2011
- Self-Reported Hepatitis C Virus Antibody Status and Risk Behavior in Young InjectorsPublic Health Reports®, 2006